Strategic Science & Technologies, LLC
Records under this name other than the patents Strategic Science & Technologies, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Showing 1 to 9 of 9 · Back to Strategic Science & Technologies, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,050,365 | Transdermal delivery of beneficial substances effected by a hostile biophysical environment Term ended Term ended Mar 15, 2026 · From the USPTO record | Term ended | Term ended Mar 15, 2026 | From the USPTO record |
| US 9,226,909 | Beneficial effects of increasing local blood flow Term ended Term ended Jan 5, 2026 · From the USPTO record | Term ended | Term ended Jan 5, 2026 | From the USPTO record |
| US 7,629,384 | Topical delivery of L-arginine to cause beneficial effects Lapsed on the fee record Ended Dec 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2017 | From the USPTO record |
| US 6,207,713 | Topical and oral delivery of arginine to cause beneficial effects Term ended Term ended Sep 17, 2017 · From the USPTO record | Term ended | Term ended Sep 17, 2017 | From the USPTO record |
| US 6,458,841 | Topical and oral delivery of arginine to cause beneficial effects Term ended Term ended Sep 17, 2017 · From the USPTO record | Term ended | Term ended Sep 17, 2017 | From the USPTO record |
| US 7,914,814 | Topical delivery of arginine of cause beneficial effects Term ended Ended no later than Sep 17, 2017 · From the USPTO record | Term ended | Ended no later than Sep 17, 2017 | From the USPTO record |
| US 8,603,519 | Topical delivery of L-arginine to cause beneficial effects Term ended Ended no later than Sep 17, 2017 · From the USPTO record | Term ended | Ended no later than Sep 17, 2017 | From the USPTO record |
| US 5,895,658 | Topical delivery of L-arginine to cause tissue warming Term ended Term ended no later than Apr 20, 2019 · Low confidence | Term ended | Term ended no later than Apr 20, 2019 | Low confidence |
| US 5,922,332 | Topical delivery of arginine to overcome pain Term ended Term ended no later than Jul 13, 2019 · Low confidence | Term ended | Term ended no later than Jul 13, 2019 | Low confidence |